{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-001419","form_type":"8-K","ticker":"VXRT","cik":"0000072444","company_name":"Vaxart, Inc.","filed_at":"2024-01-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.762647+00:00","generated_at":"2026-06-06T23:36:22.416931+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Vaxart raises $10M via registered direct offering of 15.4M shares at $0.65/share","bullets":["Sold 15,384,615 shares to RA Capital Management at $0.65 per share for gross proceeds of $10.0M.","Proceeds to be used for general corporate purposes including working capital and operating expenses.","Offering is expected to close on or about January 18, 2024, subject to customary conditions.","Shares are offered under an existing shelf registration statement on Form S-3."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-001419","json":"https://secwatch.observer/filing/0001437749-24-001419.json","markdown":"https://secwatch.observer/filing/0001437749-24-001419.md","text":"https://secwatch.observer/filing/0001437749-24-001419.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/72444/000143774924001419/0001437749-24-001419-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/72444/000143774924001419/vxrt20240116_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T23:36:22.416931+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d8bfe577b05b365439187edf534eb720f5f1cf15","claim":"Vaxart, Inc. entered into Securities Purchase Agreement with RA Capital Healthcare Fund, L.P valued at approximately $10 million (effective 2024-01-16).","evidence_excerpt":"On January 16, 2024, Vaxart, Inc. (the “Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with RA Capital Healthcare Fund, L.P (“RA Capital”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/72444/000143774924001419/0001437749-24-001419-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"RA Capital Healthcare Fund, L.P"},{"label":"Value","value":"approximately $10 million"},{"label":"Effective","value":"2024-01-16"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}